Identification of Immune Targets in Psoriatic Arthritis

银屑病关节炎免疫靶点的鉴定

基本信息

  • 批准号:
    7674130
  • 负责人:
  • 金额:
    $ 1.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

Progress Report P&F 6 - Identification of Immune Targets in Psoriatic Arthritis PI: Mark Soloski, Ph.D. We propose a series of studies aimed at identifying candidate molecular species targeted for immune recognition in Psoriatic Arthritis. In this study, we propose to: 1. Screen serum from Psoriatic Arthritis (PsA) patients and normal controls for the presence of antibodies reactive toward cellular protein species. 2. Identify and characterize the molecular species targeted for recognition by autoantiboclies in PsA using a proteomics based approach. In the initial phases of this study we have collected and archived serum, PMBCs and affected and unaffected skin samples from 43 normal and 23 PsA patients. In addition we have established a western blotting approach that we will employ to help identify proteins species targeted for recognition by PsA autoimmune serum. To date we have successfully tested keratinocyte cellular extracts with this western blotting approach for the presence of autoantigens targeted in SLE (U160k and PARP) and found the approach sensitive and reliable. We are currently generating cell extracts for a range of cell types which will be utilized in this approach.
进展报告

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark J Soloski其他文献

Mark J Soloski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark J Soloski', 18)}}的其他基金

"Innate Immune Lymphocytes and the Gut Epithelium"
“先天免疫淋巴细胞和肠上皮”
  • 批准号:
    7860355
  • 财政年份:
    2009
  • 资助金额:
    $ 1.16万
  • 项目类别:
"Innate Immune Lymphocytes and the Gut Epithelium"
“先天免疫淋巴细胞和肠上皮”
  • 批准号:
    7707042
  • 财政年份:
    2009
  • 资助金额:
    $ 1.16万
  • 项目类别:
Flow Cytometry Core Center BD FACSAria
流式细胞术核心中心 BD FACSAria
  • 批准号:
    7214920
  • 财政年份:
    2007
  • 资助金额:
    $ 1.16万
  • 项目类别:
Core C - Flow Cytometry Core
核心 C - 流式细胞仪核心
  • 批准号:
    8380932
  • 财政年份:
    2006
  • 资助金额:
    $ 1.16万
  • 项目类别:
Core C - Flow Cytometry Core
核心 C - 流式细胞仪核心
  • 批准号:
    8913755
  • 财政年份:
    2006
  • 资助金额:
    $ 1.16万
  • 项目类别:
Core C - Flow Cytometry Core
核心 C - 流式细胞术核心
  • 批准号:
    8209370
  • 财政年份:
    2006
  • 资助金额:
    $ 1.16万
  • 项目类别:
Core C - Flow Cytometry Core
核心 C - 流式细胞仪核心
  • 批准号:
    8535519
  • 财政年份:
    2006
  • 资助金额:
    $ 1.16万
  • 项目类别:
Core C - Flow Cytometry Core
核心 C - 流式细胞术核心
  • 批准号:
    8725579
  • 财政年份:
    2006
  • 资助金额:
    $ 1.16万
  • 项目类别:
Innate Cellular Elements and Enteric Bacterial Infection
先天细胞元件和肠道细菌感染
  • 批准号:
    6988885
  • 财政年份:
    2005
  • 资助金额:
    $ 1.16万
  • 项目类别:
Innate Cellular Elements and Enteric Bacterial Infection
先天细胞元件和肠道细菌感染
  • 批准号:
    7140557
  • 财政年份:
    2005
  • 资助金额:
    $ 1.16万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 1.16万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 1.16万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 1.16万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.16万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 1.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 1.16万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 1.16万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 1.16万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 1.16万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 1.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了